NCT00088790View on ClinicalTrials.gov

AZD5438 in Patients With Advanced Solid Malignancies

PHASE1CompletedINTERVENTIONAL

Timeline

Start Date

July 31, 2004

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2005

Conditions

Neoplasms

Interventions

DRUG

AZD5438

Trial Locations (2)

Unknown

Research Site, Boston

Research Site, New York

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY